|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.7 TWD | +1.21% |
|
+1.21% | +14.80% |
| 19/03 | BIONET Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | BIONET Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
BIONET Corp. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 921.42 million compared to TWD 806.58 million a year ago.
Net income was TWD 26.62 million compared to TWD 12.74 million a year ago. Basic earnings per share from continuing operations was TWD 0.56 compared to TWD 0.27 a year ago. Diluted earnings per share from continuing operations was TWD 0.56 compared to TWD 0.27 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +14.80% | 96.33M | |
| +26.90% | 49.18B | |
| +0.99% | 42.11B | |
| +50.47% | 40.37B | |
| -5.26% | 28.85B | |
| +13.80% | 26.09B | |
| -22.32% | 18.71B | |
| +7.73% | 13.26B | |
| +32.50% | 12.32B | |
| +0.29% | 11.99B |
BIONET CORP. 
